Randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer
Chemotherapy-induced peripheral neuropathy is commonly observed in patients treated with nanoparticle albumin–bound paclitaxel (nab-PTX). We conducted a multicenter randomized controlled study to evaluate the optimal dose of nab-PTX.
Gespeichert in:
| Autor*in: |
Tsurutani, Junji [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2021 |
|---|
| Schlagwörter: |
Nanoparticle albumin–bound paclitaxel |
|---|
| Umfang: |
6 |
|---|
| Übergeordnetes Werk: |
Enthalten in: The clinical outcomes of endovenous microwave and laser ablation for varicose veins: A prospective study - Yang, Lin ELSEVIER, 2020, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:55 ; year:2021 ; pages:63-68 ; extent:6 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.breast.2020.12.002 |
|---|
| Katalog-ID: |
ELV05296955X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV05296955X | ||
| 003 | DE-627 | ||
| 005 | 20230624191024.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210910s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.breast.2020.12.002 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001324.pica |
| 035 | |a (DE-627)ELV05296955X | ||
| 035 | |a (ELSEVIER)S0960-9776(20)30231-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.65 |2 bkl | ||
| 100 | 1 | |a Tsurutani, Junji |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer |
| 264 | 1 | |c 2021 | |
| 300 | |a 6 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Chemotherapy-induced peripheral neuropathy is commonly observed in patients treated with nanoparticle albumin–bound paclitaxel (nab-PTX). We conducted a multicenter randomized controlled study to evaluate the optimal dose of nab-PTX. | ||
| 650 | 7 | |a Solvent-base paclitaxel |2 Elsevier | |
| 650 | 7 | |a Nanoparticle albumin–bound paclitaxel |2 Elsevier | |
| 650 | 7 | |a Metastatic breast cancer |2 Elsevier | |
| 650 | 7 | |a Chemotherapy-induced peripheral neuropathy |2 Elsevier | |
| 650 | 7 | |a Nab-paclitaxel |2 Elsevier | |
| 700 | 1 | |a Hara, Fumikata |4 oth | |
| 700 | 1 | |a Kitada, Masahiro |4 oth | |
| 700 | 1 | |a Takahashi, Masato |4 oth | |
| 700 | 1 | |a Kikawa, Yuichiro |4 oth | |
| 700 | 1 | |a Kato, Hiroaki |4 oth | |
| 700 | 1 | |a Sakata, Eiko |4 oth | |
| 700 | 1 | |a Naito, Yoichi |4 oth | |
| 700 | 1 | |a Hasegawa, Yoshie |4 oth | |
| 700 | 1 | |a Saito, Tsuyoshi |4 oth | |
| 700 | 1 | |a Iwasa, Tsutomu |4 oth | |
| 700 | 1 | |a Taira, Naruto |4 oth | |
| 700 | 1 | |a Takashima, Tsutomu |4 oth | |
| 700 | 1 | |a Kashiwabara, Kosuke |4 oth | |
| 700 | 1 | |a Aihara, Tomohiko |4 oth | |
| 700 | 1 | |a Mukai, Hirofumi |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Yang, Lin ELSEVIER |t The clinical outcomes of endovenous microwave and laser ablation for varicose veins: A prospective study |d 2020 |g Amsterdam [u.a.] |w (DE-627)ELV004843835 |
| 773 | 1 | 8 | |g volume:55 |g year:2021 |g pages:63-68 |g extent:6 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.breast.2020.12.002 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 44.65 |j Chirurgie |q VZ |
| 951 | |a AR | ||
| 952 | |d 55 |j 2021 |h 63-68 |g 6 | ||
| author_variant |
j t jt |
|---|---|
| matchkey_str |
tsurutanijunjiharafumikatakitadamasahiro:2021----:admzdhsisuyoeemntepiadso3ekylnbaltxlnain |
| hierarchy_sort_str |
2021 |
| bklnumber |
44.65 |
| publishDate |
2021 |
| allfields |
10.1016/j.breast.2020.12.002 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001324.pica (DE-627)ELV05296955X (ELSEVIER)S0960-9776(20)30231-9 DE-627 ger DE-627 rakwb eng 610 VZ 44.65 bkl Tsurutani, Junji verfasserin aut Randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer 2021 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Chemotherapy-induced peripheral neuropathy is commonly observed in patients treated with nanoparticle albumin–bound paclitaxel (nab-PTX). We conducted a multicenter randomized controlled study to evaluate the optimal dose of nab-PTX. Solvent-base paclitaxel Elsevier Nanoparticle albumin–bound paclitaxel Elsevier Metastatic breast cancer Elsevier Chemotherapy-induced peripheral neuropathy Elsevier Nab-paclitaxel Elsevier Hara, Fumikata oth Kitada, Masahiro oth Takahashi, Masato oth Kikawa, Yuichiro oth Kato, Hiroaki oth Sakata, Eiko oth Naito, Yoichi oth Hasegawa, Yoshie oth Saito, Tsuyoshi oth Iwasa, Tsutomu oth Taira, Naruto oth Takashima, Tsutomu oth Kashiwabara, Kosuke oth Aihara, Tomohiko oth Mukai, Hirofumi oth Enthalten in Elsevier Yang, Lin ELSEVIER The clinical outcomes of endovenous microwave and laser ablation for varicose veins: A prospective study 2020 Amsterdam [u.a.] (DE-627)ELV004843835 volume:55 year:2021 pages:63-68 extent:6 https://doi.org/10.1016/j.breast.2020.12.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.65 Chirurgie VZ AR 55 2021 63-68 6 |
| spelling |
10.1016/j.breast.2020.12.002 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001324.pica (DE-627)ELV05296955X (ELSEVIER)S0960-9776(20)30231-9 DE-627 ger DE-627 rakwb eng 610 VZ 44.65 bkl Tsurutani, Junji verfasserin aut Randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer 2021 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Chemotherapy-induced peripheral neuropathy is commonly observed in patients treated with nanoparticle albumin–bound paclitaxel (nab-PTX). We conducted a multicenter randomized controlled study to evaluate the optimal dose of nab-PTX. Solvent-base paclitaxel Elsevier Nanoparticle albumin–bound paclitaxel Elsevier Metastatic breast cancer Elsevier Chemotherapy-induced peripheral neuropathy Elsevier Nab-paclitaxel Elsevier Hara, Fumikata oth Kitada, Masahiro oth Takahashi, Masato oth Kikawa, Yuichiro oth Kato, Hiroaki oth Sakata, Eiko oth Naito, Yoichi oth Hasegawa, Yoshie oth Saito, Tsuyoshi oth Iwasa, Tsutomu oth Taira, Naruto oth Takashima, Tsutomu oth Kashiwabara, Kosuke oth Aihara, Tomohiko oth Mukai, Hirofumi oth Enthalten in Elsevier Yang, Lin ELSEVIER The clinical outcomes of endovenous microwave and laser ablation for varicose veins: A prospective study 2020 Amsterdam [u.a.] (DE-627)ELV004843835 volume:55 year:2021 pages:63-68 extent:6 https://doi.org/10.1016/j.breast.2020.12.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.65 Chirurgie VZ AR 55 2021 63-68 6 |
| allfields_unstemmed |
10.1016/j.breast.2020.12.002 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001324.pica (DE-627)ELV05296955X (ELSEVIER)S0960-9776(20)30231-9 DE-627 ger DE-627 rakwb eng 610 VZ 44.65 bkl Tsurutani, Junji verfasserin aut Randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer 2021 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Chemotherapy-induced peripheral neuropathy is commonly observed in patients treated with nanoparticle albumin–bound paclitaxel (nab-PTX). We conducted a multicenter randomized controlled study to evaluate the optimal dose of nab-PTX. Solvent-base paclitaxel Elsevier Nanoparticle albumin–bound paclitaxel Elsevier Metastatic breast cancer Elsevier Chemotherapy-induced peripheral neuropathy Elsevier Nab-paclitaxel Elsevier Hara, Fumikata oth Kitada, Masahiro oth Takahashi, Masato oth Kikawa, Yuichiro oth Kato, Hiroaki oth Sakata, Eiko oth Naito, Yoichi oth Hasegawa, Yoshie oth Saito, Tsuyoshi oth Iwasa, Tsutomu oth Taira, Naruto oth Takashima, Tsutomu oth Kashiwabara, Kosuke oth Aihara, Tomohiko oth Mukai, Hirofumi oth Enthalten in Elsevier Yang, Lin ELSEVIER The clinical outcomes of endovenous microwave and laser ablation for varicose veins: A prospective study 2020 Amsterdam [u.a.] (DE-627)ELV004843835 volume:55 year:2021 pages:63-68 extent:6 https://doi.org/10.1016/j.breast.2020.12.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.65 Chirurgie VZ AR 55 2021 63-68 6 |
| allfieldsGer |
10.1016/j.breast.2020.12.002 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001324.pica (DE-627)ELV05296955X (ELSEVIER)S0960-9776(20)30231-9 DE-627 ger DE-627 rakwb eng 610 VZ 44.65 bkl Tsurutani, Junji verfasserin aut Randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer 2021 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Chemotherapy-induced peripheral neuropathy is commonly observed in patients treated with nanoparticle albumin–bound paclitaxel (nab-PTX). We conducted a multicenter randomized controlled study to evaluate the optimal dose of nab-PTX. Solvent-base paclitaxel Elsevier Nanoparticle albumin–bound paclitaxel Elsevier Metastatic breast cancer Elsevier Chemotherapy-induced peripheral neuropathy Elsevier Nab-paclitaxel Elsevier Hara, Fumikata oth Kitada, Masahiro oth Takahashi, Masato oth Kikawa, Yuichiro oth Kato, Hiroaki oth Sakata, Eiko oth Naito, Yoichi oth Hasegawa, Yoshie oth Saito, Tsuyoshi oth Iwasa, Tsutomu oth Taira, Naruto oth Takashima, Tsutomu oth Kashiwabara, Kosuke oth Aihara, Tomohiko oth Mukai, Hirofumi oth Enthalten in Elsevier Yang, Lin ELSEVIER The clinical outcomes of endovenous microwave and laser ablation for varicose veins: A prospective study 2020 Amsterdam [u.a.] (DE-627)ELV004843835 volume:55 year:2021 pages:63-68 extent:6 https://doi.org/10.1016/j.breast.2020.12.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.65 Chirurgie VZ AR 55 2021 63-68 6 |
| allfieldsSound |
10.1016/j.breast.2020.12.002 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001324.pica (DE-627)ELV05296955X (ELSEVIER)S0960-9776(20)30231-9 DE-627 ger DE-627 rakwb eng 610 VZ 44.65 bkl Tsurutani, Junji verfasserin aut Randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer 2021 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Chemotherapy-induced peripheral neuropathy is commonly observed in patients treated with nanoparticle albumin–bound paclitaxel (nab-PTX). We conducted a multicenter randomized controlled study to evaluate the optimal dose of nab-PTX. Solvent-base paclitaxel Elsevier Nanoparticle albumin–bound paclitaxel Elsevier Metastatic breast cancer Elsevier Chemotherapy-induced peripheral neuropathy Elsevier Nab-paclitaxel Elsevier Hara, Fumikata oth Kitada, Masahiro oth Takahashi, Masato oth Kikawa, Yuichiro oth Kato, Hiroaki oth Sakata, Eiko oth Naito, Yoichi oth Hasegawa, Yoshie oth Saito, Tsuyoshi oth Iwasa, Tsutomu oth Taira, Naruto oth Takashima, Tsutomu oth Kashiwabara, Kosuke oth Aihara, Tomohiko oth Mukai, Hirofumi oth Enthalten in Elsevier Yang, Lin ELSEVIER The clinical outcomes of endovenous microwave and laser ablation for varicose veins: A prospective study 2020 Amsterdam [u.a.] (DE-627)ELV004843835 volume:55 year:2021 pages:63-68 extent:6 https://doi.org/10.1016/j.breast.2020.12.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.65 Chirurgie VZ AR 55 2021 63-68 6 |
| language |
English |
| source |
Enthalten in The clinical outcomes of endovenous microwave and laser ablation for varicose veins: A prospective study Amsterdam [u.a.] volume:55 year:2021 pages:63-68 extent:6 |
| sourceStr |
Enthalten in The clinical outcomes of endovenous microwave and laser ablation for varicose veins: A prospective study Amsterdam [u.a.] volume:55 year:2021 pages:63-68 extent:6 |
| format_phy_str_mv |
Article |
| bklname |
Chirurgie |
| institution |
findex.gbv.de |
| topic_facet |
Solvent-base paclitaxel Nanoparticle albumin–bound paclitaxel Metastatic breast cancer Chemotherapy-induced peripheral neuropathy Nab-paclitaxel |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
The clinical outcomes of endovenous microwave and laser ablation for varicose veins: A prospective study |
| authorswithroles_txt_mv |
Tsurutani, Junji @@aut@@ Hara, Fumikata @@oth@@ Kitada, Masahiro @@oth@@ Takahashi, Masato @@oth@@ Kikawa, Yuichiro @@oth@@ Kato, Hiroaki @@oth@@ Sakata, Eiko @@oth@@ Naito, Yoichi @@oth@@ Hasegawa, Yoshie @@oth@@ Saito, Tsuyoshi @@oth@@ Iwasa, Tsutomu @@oth@@ Taira, Naruto @@oth@@ Takashima, Tsutomu @@oth@@ Kashiwabara, Kosuke @@oth@@ Aihara, Tomohiko @@oth@@ Mukai, Hirofumi @@oth@@ |
| publishDateDaySort_date |
2021-01-01T00:00:00Z |
| hierarchy_top_id |
ELV004843835 |
| dewey-sort |
3610 |
| id |
ELV05296955X |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV05296955X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624191024.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210910s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.breast.2020.12.002</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001324.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV05296955X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0960-9776(20)30231-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.65</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Tsurutani, Junji</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Chemotherapy-induced peripheral neuropathy is commonly observed in patients treated with nanoparticle albumin–bound paclitaxel (nab-PTX). We conducted a multicenter randomized controlled study to evaluate the optimal dose of nab-PTX.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Solvent-base paclitaxel</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Nanoparticle albumin–bound paclitaxel</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Metastatic breast cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Chemotherapy-induced peripheral neuropathy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Nab-paclitaxel</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hara, Fumikata</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kitada, Masahiro</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Takahashi, Masato</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kikawa, Yuichiro</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kato, Hiroaki</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sakata, Eiko</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Naito, Yoichi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hasegawa, Yoshie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Saito, Tsuyoshi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Iwasa, Tsutomu</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Taira, Naruto</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Takashima, Tsutomu</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kashiwabara, Kosuke</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Aihara, Tomohiko</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mukai, Hirofumi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Yang, Lin ELSEVIER</subfield><subfield code="t">The clinical outcomes of endovenous microwave and laser ablation for varicose veins: A prospective study</subfield><subfield code="d">2020</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV004843835</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:55</subfield><subfield code="g">year:2021</subfield><subfield code="g">pages:63-68</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.breast.2020.12.002</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.65</subfield><subfield code="j">Chirurgie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">55</subfield><subfield code="j">2021</subfield><subfield code="h">63-68</subfield><subfield code="g">6</subfield></datafield></record></collection>
|
| author |
Tsurutani, Junji |
| spellingShingle |
Tsurutani, Junji ddc 610 bkl 44.65 Elsevier Solvent-base paclitaxel Elsevier Nanoparticle albumin–bound paclitaxel Elsevier Metastatic breast cancer Elsevier Chemotherapy-induced peripheral neuropathy Elsevier Nab-paclitaxel Randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer |
| authorStr |
Tsurutani, Junji |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV004843835 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 VZ 44.65 bkl Randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer Solvent-base paclitaxel Elsevier Nanoparticle albumin–bound paclitaxel Elsevier Metastatic breast cancer Elsevier Chemotherapy-induced peripheral neuropathy Elsevier Nab-paclitaxel Elsevier |
| topic |
ddc 610 bkl 44.65 Elsevier Solvent-base paclitaxel Elsevier Nanoparticle albumin–bound paclitaxel Elsevier Metastatic breast cancer Elsevier Chemotherapy-induced peripheral neuropathy Elsevier Nab-paclitaxel |
| topic_unstemmed |
ddc 610 bkl 44.65 Elsevier Solvent-base paclitaxel Elsevier Nanoparticle albumin–bound paclitaxel Elsevier Metastatic breast cancer Elsevier Chemotherapy-induced peripheral neuropathy Elsevier Nab-paclitaxel |
| topic_browse |
ddc 610 bkl 44.65 Elsevier Solvent-base paclitaxel Elsevier Nanoparticle albumin–bound paclitaxel Elsevier Metastatic breast cancer Elsevier Chemotherapy-induced peripheral neuropathy Elsevier Nab-paclitaxel |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
f h fh m k mk m t mt y k yk h k hk e s es y n yn y h yh t s ts t i ti n t nt t t tt k k kk t a ta h m hm |
| hierarchy_parent_title |
The clinical outcomes of endovenous microwave and laser ablation for varicose veins: A prospective study |
| hierarchy_parent_id |
ELV004843835 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
The clinical outcomes of endovenous microwave and laser ablation for varicose veins: A prospective study |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV004843835 |
| title |
Randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer |
| ctrlnum |
(DE-627)ELV05296955X (ELSEVIER)S0960-9776(20)30231-9 |
| title_full |
Randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer |
| author_sort |
Tsurutani, Junji |
| journal |
The clinical outcomes of endovenous microwave and laser ablation for varicose veins: A prospective study |
| journalStr |
The clinical outcomes of endovenous microwave and laser ablation for varicose veins: A prospective study |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2021 |
| contenttype_str_mv |
zzz |
| container_start_page |
63 |
| author_browse |
Tsurutani, Junji |
| container_volume |
55 |
| physical |
6 |
| class |
610 VZ 44.65 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Tsurutani, Junji |
| doi_str_mv |
10.1016/j.breast.2020.12.002 |
| dewey-full |
610 |
| title_sort |
randomized phase ii study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer |
| title_auth |
Randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer |
| abstract |
Chemotherapy-induced peripheral neuropathy is commonly observed in patients treated with nanoparticle albumin–bound paclitaxel (nab-PTX). We conducted a multicenter randomized controlled study to evaluate the optimal dose of nab-PTX. |
| abstractGer |
Chemotherapy-induced peripheral neuropathy is commonly observed in patients treated with nanoparticle albumin–bound paclitaxel (nab-PTX). We conducted a multicenter randomized controlled study to evaluate the optimal dose of nab-PTX. |
| abstract_unstemmed |
Chemotherapy-induced peripheral neuropathy is commonly observed in patients treated with nanoparticle albumin–bound paclitaxel (nab-PTX). We conducted a multicenter randomized controlled study to evaluate the optimal dose of nab-PTX. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| title_short |
Randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer |
| url |
https://doi.org/10.1016/j.breast.2020.12.002 |
| remote_bool |
true |
| author2 |
Hara, Fumikata Kitada, Masahiro Takahashi, Masato Kikawa, Yuichiro Kato, Hiroaki Sakata, Eiko Naito, Yoichi Hasegawa, Yoshie Saito, Tsuyoshi Iwasa, Tsutomu Taira, Naruto Takashima, Tsutomu Kashiwabara, Kosuke Aihara, Tomohiko Mukai, Hirofumi |
| author2Str |
Hara, Fumikata Kitada, Masahiro Takahashi, Masato Kikawa, Yuichiro Kato, Hiroaki Sakata, Eiko Naito, Yoichi Hasegawa, Yoshie Saito, Tsuyoshi Iwasa, Tsutomu Taira, Naruto Takashima, Tsutomu Kashiwabara, Kosuke Aihara, Tomohiko Mukai, Hirofumi |
| ppnlink |
ELV004843835 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.breast.2020.12.002 |
| up_date |
2024-07-06T17:39:30.284Z |
| _version_ |
1803852259300212736 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV05296955X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624191024.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210910s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.breast.2020.12.002</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001324.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV05296955X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0960-9776(20)30231-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.65</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Tsurutani, Junji</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Chemotherapy-induced peripheral neuropathy is commonly observed in patients treated with nanoparticle albumin–bound paclitaxel (nab-PTX). We conducted a multicenter randomized controlled study to evaluate the optimal dose of nab-PTX.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Solvent-base paclitaxel</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Nanoparticle albumin–bound paclitaxel</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Metastatic breast cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Chemotherapy-induced peripheral neuropathy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Nab-paclitaxel</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hara, Fumikata</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kitada, Masahiro</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Takahashi, Masato</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kikawa, Yuichiro</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kato, Hiroaki</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sakata, Eiko</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Naito, Yoichi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hasegawa, Yoshie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Saito, Tsuyoshi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Iwasa, Tsutomu</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Taira, Naruto</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Takashima, Tsutomu</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kashiwabara, Kosuke</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Aihara, Tomohiko</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mukai, Hirofumi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Yang, Lin ELSEVIER</subfield><subfield code="t">The clinical outcomes of endovenous microwave and laser ablation for varicose veins: A prospective study</subfield><subfield code="d">2020</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV004843835</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:55</subfield><subfield code="g">year:2021</subfield><subfield code="g">pages:63-68</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.breast.2020.12.002</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.65</subfield><subfield code="j">Chirurgie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">55</subfield><subfield code="j">2021</subfield><subfield code="h">63-68</subfield><subfield code="g">6</subfield></datafield></record></collection>
|
| score |
7.3986187 |